Clinical Trial Update: Conbercept Ophthalmic Injection for Patients With Macular Edema Caused by Branch Retinal Vein Occlusion [Phase 3]

View source ↗

Summary

Phase 3 clinical trial update for conbercept ophthalmic injection in macular edema due to branch retinal vein occlusion completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Branch Retinal Vein Occlusion
• Macular Edema

Drugs mentioned

• Conbercept (conbercept)

Snippet

Sponsor: Chengdu Kanghong Biotech Co., Ltd. | Conditions: Branch Retinal Vein Occlusion, Macular Edema | Phase 3 | Status: COMPLETED